Leukocyte common antigen-related (LAR) tyrosine phosphatase positively regulates osteoblast differentiation by modulating extracellular signal-regulated kinase (ERK) activation
Tóm tắt
Protein tyrosine phosphatases (PTPs) are pivotal regulators of key cellular functions, including cell growth, differentiation, and adhesion. Previously, we reported that leukocyte common antigen-related (LAR) tyrosine phosphatase promotes osteoblast differentiation in MC3T3-E1 preosteoblast cells. In the present study, the mechanism of the regulatory action of LAR on osteoblast differentiation was investigated. The mineralization of extracellular matrix and calcium accumulation in MC3T3-E1 cells were markedly enhanced by LAR overexpression, and these effects were further increased by treatment with a MEK inhibitor. In addition, LAR overexpression dramatically reduced extracellular signal-regulated kinase (Erk) activation during osteoblast differentiation. In contrast, a marginal effect of the inactive LAR mutant on Erk activation was detected. Expression of osteoblast-related genes such as ALP, BSP, DLX5, OCN, and RUNX2, was increased by LAR overexpression during osteoblast differentiation. On the basis of these results, we propose that LAR functions as a positive regulator of osteoblast differentiation by modulating ERK activation. Therefore, LAR phosphatase could be used as a novel regulatory target protein in many bone-associated diseases, including osteoporosis.
Tài liệu tham khảo
Campbell, S.L., Khosravi-Far, R., Rossman, K.L., Clark, G.J., and Der, C.J. (1998). Increasing complexity of Ras signaling. Oncogene 17, 1395–1413.
Canalis, E., Pash, J., and Varghese, S. (1993). Skeletal growth factors. Crit. Rev. Euk. Gene Exp. 3, 155–166.
Chaudhary, L.R., and Avioli, L.V. (2000). Extracellular-signal regulated kinase signaling pathway mediates downregulation of type I procollagen gene expression by FGF-2, PDGF-BB, and okadaic acid in osteoblastic cells. J. Cell. Biochem. 76, 354–359.
de Souza Malaspina, T.S., Zambuzzi, W.F., dos Santos, C.X., Campanelli, A.P., Laurindo, F.R., Sogayar, M.C., and Granjeiro, J.M. (2009). A possible mechanism of low molecular weight protein tyrosine phosphatase (LMW-PTP) activity modulation by glutathione action during human osteoblast differentiation. Arch. Oral Biol. 54, 642–650.
Ducy, P., Schinke, T., and Karsenty, G. (2000). The osteoblast: a sophisticated fibroblast under central surveillance. Science 289, 1501–1504.
Franceschi, R.T., and Xiao, G. (2003). Regulation of the osteoblastspecific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J. Cell. Biochem. 88, 446–454.
Gordon, J.A., Tye, C.E., Sampaio, A.V., Underhill, T.M., Hunter, G.K., and Goldberg, H.A. (2007). Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. Bone 41, 462–473.
Higuchi, C., Myoui, A., Hashimoto, N., Kuriyama, K., Yoshioka, K., Yoshikawa, H., and Itoh, K. (2002). Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. J. Bone Miner. Res. 17, 1785–1794.
Hu, Y., Chan, E., Wang, S.X., and Li, B. (2003). Activation of p38 mitogen-activated protein kinase is required for osteoblast differentiation. Endocrinology 144, 2068–2074.
Hunter, T. (2000). Signaling-2000 and beyond. Cell 100, 113–127.
Jaiswal, R.K., Jaiswal, N., Bruder, S.P., Mbalaviele, G., Marshak, D.R., and Pittenger, M.F. (2000). Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J. Biol. Chem. 275, 9645–9652.
Jung, H., Kim, W.K., Kim, D.H., Cho, Y.S., Kim, S.J., Park, S.G., Park, B.C., Lim, H.M., Bae, K.-H., and Lee, S.C. (2009). Involvement of PTP-RQ in differentiation during adipogenesis of human mesenchymal stem cells. Biochem. Biophys. Res. Commun. 383, 252–257.
Karsenty, G. (2008). Transcriptional control of skeletogenesis. Annu. Rev. Genomics Hum. Genet. 9, 183–196.
Khan, S.N., Bostrom, M.P., and Lane, J.M. (2000). Bone growth factors. Orthop. Clin. North Am. 31, 375–388.
Kim, W.K., Jung, H., Kim, D.H., Kim, E.Y., Chung, J.W., Cho, Y.S., Park, S.G., Park, B.C., Ko, Y., Bae, K.-H., et al. (2009). Regulation of adipogenic differentiation by LAR tyrosine phosphatase in human mesenchymal stem cells and 3T3-L1 preadipocytes. J. Cell Sci. 122, 4160–4167.
Kono, S.J., Oshima, Y., Hoshi, K., Bonewald, L.F., Oda, H., Nakamura, K., Kawaguchi, H., and Tanaka, S. (2007). Erk pathways negatively regulate matrix mineralization. Bone 40, 68–74.
Kretzschmar, M., Doody, J., and Massague, J. (1997). Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature 389, 618–622.
Kulas, D.T., Goldstein, B.J., and Mooney, R.A. (1996). The transmembrane protein-tyrosine phosphatase LAR modulates signaling by multiple receptor tyrosine kinases. J. Biol. Chem. 271, 748–754.
Lai, C.F., Chaudhary, L., Fausto, A., Halstead, L.R., Ory, D.S., Avioli, L.V., and Cheng, S.L. (2001). Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J. Biol. Chem. 276, 14443–14450.
Lee, S.-J., Lee, H.-K., Cho, S.Y., Choi, J.-K., Shin, H.K., Kwak, E.-J., Cho, M.-R., Kim, H.-R., Kim, S.-R., Kim, Y.-M., et al. (2008). Identification of osteogenic purmorphamine derivatives. Mol. Cells 26, 380–386.
Mitin, N., Rossman, K.L., and Der, C.J. (2005). Signaling interplay in Ras superfamily function. Curr. Biol. 15, R563–574.
Mizuno, M., and Kuboki, Y. (2001). Osteoblast-related gene expression of bone marrow cells during the osteoblastic differentiation induced by type I collagen. J. Biochem. 129, 133–138.
Mundy, G.R. (1996). Regulation of bone formation by bone morphogenetic proteins and other growth factors. Clin. Orthop. Relat. Res. 324, 24–28.
Ory, S., and Morrison, D.K. (2004). Signal transduction: implications for Ras-dependent ERK signaling. Curr. Biol. 14, R277–278.
Ryoo, H.M., Hoffmann, H.M., Beumer, T., Frenkel, B., Towler, D.A., Stein, G.S., Stein, J.L., van Wijnen, A.J., and Lian, J.B. (1997). Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression. Mol. Endocrinol. 11, 1681–1694.
Schinke, T., Gebauer, M., Schilling, A.F., Lamprianou, S., Priemel, M., Mueldner, C., Neunaber, C., Streichert, T., Ignatius, A., Harroch, S., et al. (2008). The protein tyrosine phosphatase Rptpζ is expressed in differentiated osteoblasts and affects bone formation in mice. Bone 42, 524–534.
Seger, R., and Krebs, E.G. (1995). The MAPK signaling cascade. FASEB J. 9, 726–735.
Stanford, C.M., Jacobson, P.A., Eanes, E.D., Lembke, L.A., and Midura, R.J. (1995). Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J. Biol. Chem. 270, 9420–9428.
Wheeler, M.A., Townsend, M.K., Yunker, L.A., and Mauro, L.J. (2002). Transcriptional activation of the tyrosine phosphatase gene, OST-PTP, during osteoblast differentiation. J. Cell. Biochem. 87, 363–376.
Xiao, G., Jiang, D., Thomas, P., Benson, M.D., Guan, K., Karsenty, G., and Franceschi, R.T. (2000). MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J. Biol. Chem. 275, 4453–4459.
Xiao, G., Gopalakrishnan, R., Jiang, D., Reith, E., Benson, M.D., and Franceschi, R.T. (2002). Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J. Bone Miner. Res. 17, 101–110.
Zhang, Z.Y. (2002). Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development. Annu. Rev. Pharmacol. Toxicol. 42, 209–234.
Zhang, W., and Liu, H.T. (2002). MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 12, 9–18.